HK2194A - Use of creosote as an antispasmodic agent - Google Patents

Use of creosote as an antispasmodic agent

Info

Publication number
HK2194A
HK2194A HK21/94A HK2194A HK2194A HK 2194 A HK2194 A HK 2194A HK 21/94 A HK21/94 A HK 21/94A HK 2194 A HK2194 A HK 2194A HK 2194 A HK2194 A HK 2194A
Authority
HK
Hong Kong
Prior art keywords
creosote
antispasmodic agent
antispasmodic
agent
Prior art date
Application number
HK21/94A
Other languages
English (en)
Inventor
Tatsuya Baba
Norio Ogata
Original Assignee
Taiko Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiko Pharmaceutical Co Ltd filed Critical Taiko Pharmaceutical Co Ltd
Publication of HK2194A publication Critical patent/HK2194A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK21/94A 1989-06-01 1994-01-06 Use of creosote as an antispasmodic agent HK2194A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14082089 1989-06-01
JP1247781A JPH0625056B2 (ja) 1989-06-01 1989-09-21 鎮痙剤

Publications (1)

Publication Number Publication Date
HK2194A true HK2194A (en) 1994-01-14

Family

ID=26473230

Family Applications (1)

Application Number Title Priority Date Filing Date
HK21/94A HK2194A (en) 1989-06-01 1994-01-06 Use of creosote as an antispasmodic agent

Country Status (8)

Country Link
US (1) US5112872A (xx)
EP (1) EP0400219B1 (xx)
JP (1) JPH0625056B2 (xx)
KR (1) KR910000130A (xx)
CA (1) CA2005072C (xx)
DE (1) DE68910676T2 (xx)
HK (1) HK2194A (xx)
PH (1) PH27336A (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2545321B2 (ja) * 1992-08-21 1996-10-16 大幸薬品株式会社 平滑筋収縮抑制剤
GB9308469D0 (en) * 1993-04-23 1993-06-09 Wright George H Management of cholelithiasis
JP3074519B2 (ja) * 1996-07-01 2000-08-07 大幸薬品株式会社 腸液吸収促進剤
JP2006192922A (ja) * 2005-01-11 2006-07-27 Shigeru Co Ltd 車両用内装品における装着凹部の形成方法
US7390816B2 (en) * 2005-06-21 2008-06-24 Bridge Pharma, Inc. Methods for treating urinary incontinence in patients suffering from memory disorders
US20060287347A1 (en) * 2005-06-21 2006-12-21 Aberg A K G Methods for treating smooth muscle disorders using trospium
US20070004766A1 (en) * 2005-07-01 2007-01-04 Aberg A K G Methods for relaxation of smooth muscle contractions using Trospium
WO2013146471A1 (ja) * 2012-03-28 2013-10-03 大幸薬品株式会社 薬剤組成物、及びこれを密封してなる軟カプセル剤
EP3923916A4 (en) 2019-02-15 2022-12-21 Saol International Development Ltd. INJECTABLE PHENOL FORMULATIONS AND METHODS OF USE
KR102428859B1 (ko) * 2020-05-29 2022-08-04 동성제약주식회사 안전성이 확보된 소화기계 질환 예방 또는 치료를 위한 경구투여용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608258A (en) * 1983-08-17 1986-08-26 Taiko Pharmaceutical Co., Ltd. Medicament for treatment of diarrhea
JPS62142132A (ja) * 1985-12-16 1987-06-25 Tanpei Seiyaku Kk 新規包接化合物

Also Published As

Publication number Publication date
PH27336A (en) 1993-06-08
CA2005072C (en) 1994-12-06
EP0400219A3 (en) 1991-01-16
JPH0386817A (ja) 1991-04-11
DE68910676T2 (de) 1994-05-26
US5112872A (en) 1992-05-12
EP0400219A2 (en) 1990-12-05
KR910000130A (ko) 1991-01-29
DE68910676D1 (de) 1993-12-16
EP0400219B1 (en) 1993-11-10
JPH0625056B2 (ja) 1994-04-06

Similar Documents

Publication Publication Date Title
GB8907298D0 (en) Composition and use
EP0282294A3 (en) Vinylsilylalkoxy arylbenzotriazole compounds and uv absorbing compositions made therefrom
NZ235192A (en) Oxirane derivatives and fungicidal compositions
GR3000698T3 (en) Wood protecting agent
HK2194A (en) Use of creosote as an antispasmodic agent
GB9006201D0 (en) Skin composition
GB8813576D0 (en) Composition & use
GB8811948D0 (en) Composition & use
EP0386359A3 (en) Konjak-containing composition
GB8909614D0 (en) Command-curable composition
GB8916151D0 (en) Composition
SG141293G (en) Use of creosote as an antispasmodic agent
ZA90483B (en) Compound and use
CS538989A1 (en) Wood protection agent
EP0434164A3 (en) Frying-fat composition
IE891352L (en) Preservative mixture
GB8929025D0 (en) Compound and use
YU36390A (en) Biocidic compositions and their use
GB8907588D0 (en) Therapeutic compound and composition
GB9015161D0 (en) Preparation of pentachlorophenol
PL275170A1 (en) Agent for improving properties of viscose
CS529589A3 (en) Varrocidal agent
GB8912355D0 (en) Protection of surfaces
GB8900122D0 (en) Composition of matter
IE900317L (en) Use of oxoquinazoline derivatives

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20091206